JAZZ vs QNST · P/E 1988, rev $2.28B vs rev $1.29B
Jazz Pharmaceuticals PLC (JAZZ) versus QuinStreet Inc (QNST) — a side-by-side from cached financials, not a winner call.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
QuinStreet Inc (QNST) is a advertising agencies company listed on US.
Latest reported JAZZ revenue for 2026-06-30 was $2.28B. Net income was $485.9M. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Latest reported QNST revenue for 2026-06-30 was $1.29B. Net income was $81.2M. Revenue was up 18.3% from 2025-06-30 to 2026-06-30. QNST currently screens at market cap $874.8M.
JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1. QNST currently screens at market cap $874.8M.
Not investment advice. Open the JAZZ and QNST stock pages for the full models.
Not investment advice.